Wissenschaftl. Titel | A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate Efficacy and Safety of Upadacitinib in Adult and Adolescent Subjects with Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy |
Erkrankung |
Haut:
Acne inversa
|
weitere Prüfzentren | |
Kurzprotokoll | Kurzprotokoll |
erstellt 19.02.2025 Admin07
geändert 19.02.2025 Admin07